The Project Mainly Produces Biological Preparations and Natural Polysaccharides

The project mainly produces biological preparations and natural polysaccharides. The newly developed trehalose has low endotoxin and good human adaptability, effectively reducing allergic and painful reactions during the infusion process, breaking the situation of China's reliance on imports from Japan. The production of ursodeoxycholic acid is in short supply, with orders from countries such as the US and Germany exceeding 5 million US dollars. The company holds 21 patents, among which the low-endotoxin trehalose preparation technology fills the gap in China's intellectual property rights for pharmaceutical-grade trehalose. After the project is fully put into production, it will produce 15,000 tons of products such as trehalose and allulose annually, mainly sold to internationally renowned enterprises like By-Health and Lilly, and exported to more than ten countries in Europe and America.